Biopsy Devices Market Size, Share, Trends, Growth Outlook

Biopsy Devices Market is estimated to increase at a Compounded Annual Growth Rate of 15.2% CAGR over the forecast period from 2024 to 2030

The Biopsy Devices Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (Needle Based Biopsy Instruments, Liquid Biopsy Instruments, Localization Wire, Biopsy Forceps, Procedure Tray, Biopsy Table, Others), By Technique (Image Guided Biopsy, Non-Image Guided Biopsy), By Application (Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer, Bone Marrow Biopsy, Others), By End-User (Hospitals and Breast Care Centers, Diagnostic Imaging Centers, Research and Academic Institutes, Others).

An Introduction to Biopsy Devices Market in 2024

Biopsy devices are medical instruments used to obtain tissue samples from the body for diagnostic evaluation and pathological analysis. In 2024, the field of biopsy devices continues to advance with the development of minimally invasive techniques, improved imaging guidance, and enhanced tissue sampling capabilities aimed at optimizing diagnostic accuracy and patient comfort. From core biopsy needles and vacuum-assisted biopsy systems to endoscopic biopsy forceps and image-guided biopsy probes, healthcare providers have access to a variety of tools tailored to different anatomical sites and clinical indications. Moreover, with the integration of advanced imaging modalities such as ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT), biopsy procedures can be performed with greater precision and real-time visualization, facilitating accurate targeting of suspicious lesions and minimizing the risk of sampling errors. By enabling early detection and characterization of diseases such as cancer, inflammatory conditions, and infectious diseases, biopsy devices play a crucial role in guiding treatment decisions, monitoring disease progression, and improving patient outcomes across a wide range of medical specialties.

Market Trend: Shift Towards Minimally Invasive Biopsy Procedures

A significant trend in the biopsy devices market is the shift towards minimally invasive biopsy procedures for the diagnosis and staging of various diseases, including cancer and infectious diseases. Minimally invasive biopsy techniques, such as fine needle aspiration (FNA), core needle biopsy (CNB), and vacuum-assisted biopsy (VAB), offer advantages over traditional open surgical biopsies, including reduced patient discomfort, shorter recovery times, and lower healthcare costs. Additionally, advances in imaging technologies, such as ultrasound, MRI, and CT, enable more precise targeting of lesions and improved diagnostic accuracy, facilitating the adoption of minimally invasive biopsy approaches in both outpatient and inpatient settings. This trend towards minimally invasive biopsy procedures drives the demand for innovative biopsy devices and technologies that enable clinicians to obtain high-quality tissue samples for pathological analysis while minimizing patient trauma and procedural risks.

Market Driver: Growing Incidence of Cancer and Chronic Diseases

The primary driver fueling the growth of the biopsy devices market is the growing incidence of cancer and chronic diseases worldwide. Cancer remains a leading cause of morbidity and mortality globally, driving the demand for diagnostic tools and procedures that enable early detection, accurate staging, and personalized treatment planning. Biopsy devices play a critical role in the diagnosis and management of cancer, enabling clinicians to obtain tissue samples for histological analysis, molecular profiling, and biomarker testing to guide treatment decisions. Additionally, the rising prevalence of chronic diseases, such as cardiovascular diseases, liver diseases, and infectious diseases, contributes to the demand for biopsy devices used in the diagnosis and monitoring of disease progression and treatment response. As the global burden of cancer and chronic diseases continues to increase, the need for biopsy devices that offer high sensitivity, precision, and safety remains paramount, driving market growth and innovation in the biopsy devices industry.

Market Opportunity: Integration of Imaging Guidance and Molecular Diagnostics

A potential opportunity lies in the integration of imaging guidance and molecular diagnostics into biopsy devices to enhance diagnostic accuracy and therapeutic decision-making. By combining real-time imaging modalities, such as ultrasound, MRI, or optical coherence tomography (OCT), with biopsy devices, clinicians can visualize target lesions in real-time, precisely guide biopsy needle placement, and confirm tissue sampling adequacy, reducing the need for repeat procedures and improving diagnostic yield. Furthermore, the integration of molecular diagnostic techniques, such as next-generation sequencing (NGS), fluorescence in situ hybridization (FISH), and immunohistochemistry (IHC), into biopsy devices enables rapid and comprehensive characterization of tissue samples, facilitating the identification of specific genetic mutations, protein expression patterns, and therapeutic targets. By integrating imaging guidance and molecular diagnostics into biopsy devices, manufacturers can offer comprehensive solutions that streamline the diagnostic workflow, improve diagnostic accuracy, and enable personalized treatment strategies, creating value-added opportunities in the evolving landscape of biopsy devices and diagnostic technologies.

Biopsy Devices Market Share Analysis: Image-Guided Biopsy Techniques is the fastest growing segment over the forecast period to 2030

Within the Biopsy Devices Market, the segment experiencing the fastest growth is Image-Guided Biopsy, particularly Ultrasound Guided Biopsy and Stereotactic Guided Biopsy. This surge can be attributed to the increasing adoption of advanced imaging technologies and techniques, which enhance the accuracy and precision of tissue sampling procedures. Ultrasound-guided biopsy allows real-time visualization of the target tissue, enabling clinicians to precisely guide the biopsy needle to the desired location with high accuracy and minimal invasiveness. Similarly, Stereotactic Guided Biopsy utilizes three-dimensional imaging to precisely target lesions that are not easily visible on conventional imaging modalities, such as mammography. These advancements in image-guided biopsy techniques have revolutionized cancer diagnosis and treatment by facilitating early detection of tumors, improved tissue sampling accuracy, and reduced patient discomfort. As a result, healthcare providers are increasingly investing in biopsy devices equipped with image guidance capabilities, driving significant growth in this segment of the Biopsy Devices Market.

Biopsy Devices Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossArgon Medical Devices, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corp, Cardinal Health Inc, Cook Group Inc, Devicor Medical Products Inc, FUJIFILM Holdings Corp, Hologic Inc, INRAD Inc , Medtronic plc, Olympus Corp

Biopsy Devices Market Segmentation

By Product
Needle Based Biopsy Instruments
Liquid Biopsy Instruments
Localization Wire
Biopsy Forceps
Procedure Tray
Biopsy Table
Others
By Technique
Image Guided Biopsy
-Ultrasound Guided Biopsy
-Stereotactic Guided Biopsy
-MRI Guided Biopsy
-Others
Non-Image Guided Biopsy
-Liquid Biopsy
-General Biopsy
By Application
Breast Cancer
Lung Cancer
Kidney Cancer
Prostate Cancer
Bone Marrow Biopsy
Others
By End-User
Hospitals and Breast Care Centers
Diagnostic Imaging Centers
Research and Academic Institutes
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Biopsy Devices Market Companies

Argon Medical Devices
B. Braun Melsungen AG
Becton, Dickinson and Company
Boston Scientific Corp
Cardinal Health Inc
Cook Group Inc
Devicor Medical Products Inc
FUJIFILM Holdings Corp
Hologic Inc
INRAD Inc
Medtronic plc
Olympus Corp

Reasons to Buy the Biopsy Devices Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Biopsy Devices Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Biopsy Devices Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Biopsy Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Biopsy Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Biopsy Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Biopsy Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Biopsy Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Biopsy Devices Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Biopsy Devices Industry
4.2 Key Market Trends in Biopsy Devices Industry
4.3 Potential Opportunities in Biopsy Devices Industry
4.4 Key Challenges in Biopsy Devices Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Biopsy Devices Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Biopsy Devices Market Outlook by Segments
7.1 Biopsy Devices Market Outlook by Segments, $ Million, 2021- 2030
By Product
Needle Based Biopsy Instruments
Liquid Biopsy Instruments
Localization Wire
Biopsy Forceps
Procedure Tray
Biopsy Table
Others
By Technique
Image Guided Biopsy
-Ultrasound Guided Biopsy
-Stereotactic Guided Biopsy
-MRI Guided Biopsy
-Others
Non-Image Guided Biopsy
-Liquid Biopsy
-General Biopsy
By Application
Breast Cancer
Lung Cancer
Kidney Cancer
Prostate Cancer
Bone Marrow Biopsy
Others
By End-User
Hospitals and Breast Care Centers
Diagnostic Imaging Centers
Research and Academic Institutes
Others

8 North America Biopsy Devices Market Analysis and Outlook To 2030
8.1 Introduction to North America Biopsy Devices Markets in 2024
8.2 North America Biopsy Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Biopsy Devices Market size Outlook by Segments, 2021-2030
By Product
Needle Based Biopsy Instruments
Liquid Biopsy Instruments
Localization Wire
Biopsy Forceps
Procedure Tray
Biopsy Table
Others
By Technique
Image Guided Biopsy
-Ultrasound Guided Biopsy
-Stereotactic Guided Biopsy
-MRI Guided Biopsy
-Others
Non-Image Guided Biopsy
-Liquid Biopsy
-General Biopsy
By Application
Breast Cancer
Lung Cancer
Kidney Cancer
Prostate Cancer
Bone Marrow Biopsy
Others
By End-User
Hospitals and Breast Care Centers
Diagnostic Imaging Centers
Research and Academic Institutes
Others

9 Europe Biopsy Devices Market Analysis and Outlook To 2030
9.1 Introduction to Europe Biopsy Devices Markets in 2024
9.2 Europe Biopsy Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Biopsy Devices Market Size Outlook by Segments, 2021-2030
By Product
Needle Based Biopsy Instruments
Liquid Biopsy Instruments
Localization Wire
Biopsy Forceps
Procedure Tray
Biopsy Table
Others
By Technique
Image Guided Biopsy
-Ultrasound Guided Biopsy
-Stereotactic Guided Biopsy
-MRI Guided Biopsy
-Others
Non-Image Guided Biopsy
-Liquid Biopsy
-General Biopsy
By Application
Breast Cancer
Lung Cancer
Kidney Cancer
Prostate Cancer
Bone Marrow Biopsy
Others
By End-User
Hospitals and Breast Care Centers
Diagnostic Imaging Centers
Research and Academic Institutes
Others

10 Asia Pacific Biopsy Devices Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Biopsy Devices Markets in 2024
10.2 Asia Pacific Biopsy Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Biopsy Devices Market size Outlook by Segments, 2021-2030
By Product
Needle Based Biopsy Instruments
Liquid Biopsy Instruments
Localization Wire
Biopsy Forceps
Procedure Tray
Biopsy Table
Others
By Technique
Image Guided Biopsy
-Ultrasound Guided Biopsy
-Stereotactic Guided Biopsy
-MRI Guided Biopsy
-Others
Non-Image Guided Biopsy
-Liquid Biopsy
-General Biopsy
By Application
Breast Cancer
Lung Cancer
Kidney Cancer
Prostate Cancer
Bone Marrow Biopsy
Others
By End-User
Hospitals and Breast Care Centers
Diagnostic Imaging Centers
Research and Academic Institutes
Others

11 South America Biopsy Devices Market Analysis and Outlook To 2030
11.1 Introduction to South America Biopsy Devices Markets in 2024
11.2 South America Biopsy Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Biopsy Devices Market size Outlook by Segments, 2021-2030
By Product
Needle Based Biopsy Instruments
Liquid Biopsy Instruments
Localization Wire
Biopsy Forceps
Procedure Tray
Biopsy Table
Others
By Technique
Image Guided Biopsy
-Ultrasound Guided Biopsy
-Stereotactic Guided Biopsy
-MRI Guided Biopsy
-Others
Non-Image Guided Biopsy
-Liquid Biopsy
-General Biopsy
By Application
Breast Cancer
Lung Cancer
Kidney Cancer
Prostate Cancer
Bone Marrow Biopsy
Others
By End-User
Hospitals and Breast Care Centers
Diagnostic Imaging Centers
Research and Academic Institutes
Others
12 Middle East and Africa Biopsy Devices Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Biopsy Devices Markets in 2024
12.2 Middle East and Africa Biopsy Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Biopsy Devices Market size Outlook by Segments, 2021-2030
By Product
Needle Based Biopsy Instruments
Liquid Biopsy Instruments
Localization Wire
Biopsy Forceps
Procedure Tray
Biopsy Table
Others
By Technique
Image Guided Biopsy
-Ultrasound Guided Biopsy
-Stereotactic Guided Biopsy
-MRI Guided Biopsy
-Others
Non-Image Guided Biopsy
-Liquid Biopsy
-General Biopsy
By Application
Breast Cancer
Lung Cancer
Kidney Cancer
Prostate Cancer
Bone Marrow Biopsy
Others
By End-User
Hospitals and Breast Care Centers
Diagnostic Imaging Centers
Research and Academic Institutes
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Argon Medical Devices
B. Braun Melsungen AG
Becton, Dickinson and Company
Boston Scientific Corp
Cardinal Health Inc
Cook Group Inc
Devicor Medical Products Inc
FUJIFILM Holdings Corp
Hologic Inc
INRAD Inc
Medtronic plc
Olympus Corp

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Needle Based Biopsy Instruments
Liquid Biopsy Instruments
Localization Wire
Biopsy Forceps
Procedure Tray
Biopsy Table
Others
By Technique
Image Guided Biopsy
-Ultrasound Guided Biopsy
-Stereotactic Guided Biopsy
-MRI Guided Biopsy
-Others
Non-Image Guided Biopsy
-Liquid Biopsy
-General Biopsy
By Application
Breast Cancer
Lung Cancer
Kidney Cancer
Prostate Cancer
Bone Marrow Biopsy
Others
By End-User
Hospitals and Breast Care Centers
Diagnostic Imaging Centers
Research and Academic Institutes
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)